NVC-001 is designed to target the mechanobiological root cause of LMNA dilated cardiomyopathy and has disease-modifying potential SINGAPORE, PARIS and PHILADELPHIA, Oct. 8, 2026 /PRNewswire/ -- Nuevocor, a clinical-stage biotechnology company pioneering mechanobiology-targeted therapies designed to address the root causes of life-threatening cardiomyopathies, today announced that the first...
New tabletop ice makers deliver crystal-clear square and sphere ice for elevated cocktails and premium home entertaining NEW YORK, May 29, 2026 /PRNewswire/...
NEW YORK, May 29, 2026 /PRNewswire/ -- The following report is from Deep Blue Finance: DaSouChe Holdings Ltd. ("DSC") publicly filed its registration...
HAIKOU, China, May 29, 2026 /PRNewswire/ -- A report from Hainan International Media Center: On December 18, 2025, Hainan, an island province just off...